Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-12 10:02 am Purchase | 2022-12-31 | 13G | KIROMIC BIOPHARMA INC KRBP | Empery Asset Management, LP | 163,268 9.990% | 163,268 (New Position) | Filing History |
| 2023-01-12 10:01 am Unchanged | 2022-12-31 | 13G | DIRECT DIGITAL HLDGS INC DRCT | Empery Asset Management, LP | 1,227 4.990% | 0 (Unchanged) | Filing History |
| 2023-01-12 10:01 am Sale | 2022-12-31 | 13G | ISPECIMEN INC ISPC | Empery Asset Management, LP | 547 4.680% | -36 (-6.17%) | Filing History |
| 2022-03-18 5:15 pm Purchase | 2022-02-10 | 13G | DIRECT DIGITAL HLDGS INC DRCT | Empery Asset Management, LP | 1,227 9.640% | 1,227 (New Position) | Filing History |
| 2022-01-24 10:35 am Sale | 2021-12-31 | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | Empery Asset Management, LP | 43,022 4.990% | -4,207 (-8.91%) | Filing History |
| 2022-01-24 10:33 am Sale | 2021-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Empery Asset Management, LP | 1,484 4.050% | -929 (-38.50%) | Filing History |
| 2022-01-24 10:32 am Purchase | 2021-12-31 | 13G | ISPECIMEN INC ISPC | Empery Asset Management, LP | 583 5.340% | 583 (New Position) | Filing History |
| 2022-01-24 10:30 am Purchase | 2021-12-31 | 13G | POLISHED INC.COM POL | Empery Asset Management, LP | 3,380 4.990% | 713 (+26.73%) | Filing History |
| 2022-01-24 10:28 am Purchase | 2021-12-31 | 13G | Bit Brother Ltd | Empery Asset Management, LP | 3,900,000 4.990% | 2,650,000 (+212.00%) | Filing History |
| 2022-01-20 09:55 am Sale | 2021-12-31 | 13G | PERASO INC PRSO | Empery Asset Management, LP | 184 0.080% | -12,213 (-98.52%) | Filing History |
| 2022-01-20 09:53 am Sale | 2021-12-31 | 13G | PYXIS TANKERS INC PXS | Empery Asset Management, LP | 40,000 0.420% | -674,286 (-94.40%) | Filing History |
| 2022-01-20 09:51 am Sale | 2021-12-31 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Empery Asset Management, LP | 7,306 4.990% | -1,024 (-12.29%) | Filing History |
| 2022-01-20 09:49 am Unchanged | 2021-12-31 | 13G | NUWELLIS INC NUWE | Empery Asset Management, LP | 0 4.350% | 0 (Unchanged) | Filing History |
| 2022-01-20 09:47 am Sale | 2021-12-31 | 13G | BRIACELL THERAPEUTICS INC BCTX | Empery Asset Management, LP | 3,333 2.520% | -76 (-2.23%) | Filing History |
| 2022-01-19 11:04 am Sale | 2021-12-31 | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Empery Asset Management, LP | 2,244,292 4.990% | -1,688,292 (-42.93%) | Filing History |
| 2022-01-19 11:03 am Sale | 2021-12-31 | 13G | ENVVENO MED CORP COM NVNO | Empery Asset Management, LP | 13,474 4.740% | -2,853 (-17.47%) | Filing History |
| 2022-01-19 10:48 am Sale | 2021-12-31 | 13G | HEPION PHARMACEUTICALS INC HEPA | Empery Asset Management, LP | 336 0.440% | -3,664 (-91.60%) | Filing History |
| 2022-01-19 10:46 am Sale | 2021-12-31 | 13G | ENVIROTECH VEHS INC EVTV | Empery Asset Management, LP | 2,014 2.610% | -903 (-30.96%) | Filing History |
| 2022-01-19 10:44 am Sale | 2021-12-31 | 13G | CALADRIUS BIOSCIENCES INC CLBS | Empery Asset Management, LP | 167,024 4.020% | -62,908 (-27.36%) | Filing History |
| 2022-01-18 11:21 am Unchanged | 2021-12-31 | 13G | VIVEVE MED INC PAR $ VIVE | Empery Asset Management, LP | 1,029,411 4.990% | 0 (Unchanged) | Filing History |